Entry - #616685 - EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14; EIG14 - OMIM
 
# 616685

EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14; EIG14


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
20q13.12 {Epilepsy, idiopathic generalized, susceptibility to, 14} 616685 AD 3 SLC12A5 606726
Clinical Synopsis
 
Phenotypic Series
 

INHERITANCE
- Autosomal dominant
NEUROLOGIC
Central Nervous System
- Seizures
- Generalized tonic-clonic seizures
- Absence seizures
- Myoclonic seizures
- Febrile seizures (1 family)
- Generalized spike-wave discharges seen on EEG
MISCELLANEOUS
- Variable age at onset, but most often in the first 2 decades
- Incomplete penetrance
MOLECULAR BASIS
- Susceptibility conferred by mutation in the solute carrier family 12 (potassium/chloride transporter), member 5 gene (SLC12A5, 606726.0004)
Epilepsy, idiopathic generalized - PS600669 - 27 Entries
Location Phenotype Inheritance Phenotype
mapping key
Phenotype
MIM number
Gene/Locus Gene/Locus
MIM number
1p36.33 {?Generalized epilepsy with febrile seizures plus, type 5, susceptibility to} AD 3 613060 GABRD 137163
1p34.2 {Epilepsy, idiopathic generalized, susceptibility to, 12} AD 3 614847 SLC2A1 138140
2q23.3 {Epilepsy, juvenile myoclonic, susceptibility to, 6} AD 3 607682 CACNB4 601949
2q23.3 {Epilepsy, idiopathic generalized, susceptibility to, 9} AD 3 607682 CACNB4 601949
3q13.33-q21.1 {?Epilepsy idiopathic generalized, susceptibility to, 8} AD 3 612899 CASR 601199
3q27.1 {Epilepsy, juvenile myoclonic, susceptibility to, 8} AD 3 607628 CLCN2 600570
3q27.1 {Epilepsy, idiopathic generalized, susceptibility to, 11} AD 3 607628 CLCN2 600570
3q27.1 {Epilepsy, juvenile absence, susceptibility to, 2} AD 3 607628 CLCN2 600570
5q34 {Epilepsy, juvenile myoclonic, susceptibility to, 5} 3 611136 GABRA1 137160
5q34 {Epilepsy, childhood absence, susceptibility to, 4} 3 611136 GABRA1 137160
8q24 {Epilepsy, idiopathic generalized, susceptibility to, 1} AD 2 600669 EIG1 600669
9q21.13 {Epilepsy, idiopathic generalized, susceptibility to, 15} AD 3 618357 RORB 601972
9q32-q33 {Epilepsy, idiopathic generalized, susceptibility to, 3} AR 2 608762 EIG3 608762
10p11.22 {Epilepsy, idiopathic generalized, susceptibility to, 5} 2 611934 EIG5 611934
10q22.3 {Epilepsy, idiopathic generalized, susceptibility to, 16} AD 3 618596 KCNMA1 600150
10q25-q26 {Epilepsy, idiopathic generalized, susceptibility to 4} 2 609750 EIG4 609750
14q23 {Epilepsy, idiopathic generalized, susceptibility to, 2} 2 606972 EIG2 606972
15q14 Epilepsy, juvenile myoclonic IC 2 604827 EIG7 604827
15q14 {Epilepsy, idiopathic generalized, susceptibility to, 7} IC 2 604827 EIG7 604827
15q24.1 {Epilepsy, idiopathic generalized, susceptibility to, 18} AD 3 619521 HCN4 605206
16p13.3 {Epilepsy, childhood absence, susceptibility to, 6} 3 611942 CACNA1H 607904
16p13.3 {Epilepsy, idiopathic generalized, susceptibility to, 6} 3 611942 CACNA1H 607904
19p13.3 Generalized epilepsy with febrile seizures plus, type 11 AD 3 602477 HCN2 602781
19p13.3 {Epilepsy, idiopathic generalized, susceptibility to, 17} AD 3 602477 HCN2 602781
19p13.3 Febrile seizures, familial, 2 AD 3 602477 HCN2 602781
20q13.12 {Epilepsy, idiopathic generalized, susceptibility to, 14} AD 3 616685 SLC12A5 606726
21q21.1 {Epilepsy, idiopathic generalized, susceptibility to, 19} AD 3 621064 USP25 604736

TEXT

A number sign (#) is used with this entry because of evidence that susceptibility to idiopathic generalized epilepsy-14 (EIG14) is conferred by heterozygous mutation in the SLC12A5 gene (606726) on chromosome 20q13.

For a general phenotypic description and a discussion of genetic heterogeneity of idiopathic generalized epilepsy, see EIG (600669).


Clinical Features

Kahle et al. (2014) reported 8 patients of French Canadian origin with idiopathic generalized epilepsy with onset between 3 and 21 years of age. Seizure types included generalized tonic-clonic, absence, and myoclonic. EEG results, when available, showed generalized spike-wave discharges or diffuse theta waves. None of the patients had febrile seizures.

Puskarjov et al. (2014) reported an Australian family in which several individuals had febrile seizures. Additional clinical details were not provided.


Inheritance

The transmission pattern of EIG14 in the families reported by Kahle et al. (2014) was consistent with autosomal dominant inheritance and incomplete penetrance.


Molecular Genetics

Kahle et al. (2014) identified 2 different heterozygous missense variants in the SLC12A5 gene (R952H, 606726.0004 and R1049C, 606726.0005) that were enriched among individuals of French Canadian origin with EIG14 compared to controls. The R952H variant was found in 5 of 380 patients with EIG (allele frequency of 0.66%) and in 5 of 1,214 controls (allele frequency of 0.21%), yielding an odds ratio (OR) of 3.21 for development of EIG (p = 0.065). The R1049C variant was found in 3 of 380 patients with EIG (allele frequency of 0.39) and in 1 of 1,214 controls (allele frequency of 4.12 x 10(-4)), yielding an odds ratio (OR) of 9.61 (p = 0.044). In vitro functional expression studies showed that the variants impaired chloride extrusion capacities, resulting in less hyperpolarized glycine equilibrium potentials, and also impaired stimulatory phosphorylation at residue ser940, a key regulatory site of channel function. The overall effect impaired the function of SLC12A5. The authors used a targeted DNA-sequencing approach to screen the cytoplasmic C-terminal region of SLC12A5, which is an important regulatory region of transporter function.

Puskarjov et al. (2014) identified a heterozygous R952H variant in the SLC12A5 gene in 3 affected members of an Australian family with febrile seizures. Segregation of the variant in this kindred was difficult because of uncertain phenotyping, but there was some evidence of incomplete penetrance. In vitro functional expression studies showed markedly decreased surface expression of the mutant protein (61% of wildtype) as well as decreased chloride extrusion compared to wildtype. Thus, the mutant protein was associated with deficits in maintaining the chloride driving force required for hyperpolarizing GABA-mediated responses. Transfection of the variant into rats and into mouse cortical neurons showed that it compromised dendritic spine formation and maturation. Puskarjov et al. (2014) suggested that the decrease in SLC12A5-dependent hyperpolarizing inhibition would promote triggering of seizures, and that decreased dendritic spine formation could lead to desynchronization of overall excitability, which may also contribute to seizures.


REFERENCES

  1. Kahle, K. T., Merner, N. D., Friedel, P., Silayeva, L., Liang, B., Khanna, A., Shang, Y., Lachance-Touchette, P., Bourassa, C., Levert, A., Dion, P. A., Walcott, B., and 11 others. Genetically encoded impairment of neuronal KCC2 cotransporter function in human idiopathic generalized epilepsy. EMBO Rep. 15: 766-774, 2014. [PubMed: 24928908, images, related citations] [Full Text]

  2. Puskarjov, M., Seja, P., Heron, S. E., Williams, T. C., Ahmad, F., Iona, X., Oliver, K. L., Grinton, B. E., Vutskits, L., Scheffer, I. E., Petrou, S., Blaesse, P., Dibbens, L. M., Berkovic, S. F., Kaila, K. A variant of KCC2 from patients with febrile seizures impairs neuronal Cl- extrusion and dendritic spine formation. EMBO Rep. 15: 723-729, 2014. [PubMed: 24668262, images, related citations] [Full Text]


Creation Date:
Cassandra L. Kniffin : 12/8/2015
carol : 06/14/2016
carol : 12/22/2015
ckniffin : 12/21/2015

# 616685

EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14; EIG14


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
20q13.12 {Epilepsy, idiopathic generalized, susceptibility to, 14} 616685 Autosomal dominant 3 SLC12A5 606726

TEXT

A number sign (#) is used with this entry because of evidence that susceptibility to idiopathic generalized epilepsy-14 (EIG14) is conferred by heterozygous mutation in the SLC12A5 gene (606726) on chromosome 20q13.

For a general phenotypic description and a discussion of genetic heterogeneity of idiopathic generalized epilepsy, see EIG (600669).


Clinical Features

Kahle et al. (2014) reported 8 patients of French Canadian origin with idiopathic generalized epilepsy with onset between 3 and 21 years of age. Seizure types included generalized tonic-clonic, absence, and myoclonic. EEG results, when available, showed generalized spike-wave discharges or diffuse theta waves. None of the patients had febrile seizures.

Puskarjov et al. (2014) reported an Australian family in which several individuals had febrile seizures. Additional clinical details were not provided.


Inheritance

The transmission pattern of EIG14 in the families reported by Kahle et al. (2014) was consistent with autosomal dominant inheritance and incomplete penetrance.


Molecular Genetics

Kahle et al. (2014) identified 2 different heterozygous missense variants in the SLC12A5 gene (R952H, 606726.0004 and R1049C, 606726.0005) that were enriched among individuals of French Canadian origin with EIG14 compared to controls. The R952H variant was found in 5 of 380 patients with EIG (allele frequency of 0.66%) and in 5 of 1,214 controls (allele frequency of 0.21%), yielding an odds ratio (OR) of 3.21 for development of EIG (p = 0.065). The R1049C variant was found in 3 of 380 patients with EIG (allele frequency of 0.39) and in 1 of 1,214 controls (allele frequency of 4.12 x 10(-4)), yielding an odds ratio (OR) of 9.61 (p = 0.044). In vitro functional expression studies showed that the variants impaired chloride extrusion capacities, resulting in less hyperpolarized glycine equilibrium potentials, and also impaired stimulatory phosphorylation at residue ser940, a key regulatory site of channel function. The overall effect impaired the function of SLC12A5. The authors used a targeted DNA-sequencing approach to screen the cytoplasmic C-terminal region of SLC12A5, which is an important regulatory region of transporter function.

Puskarjov et al. (2014) identified a heterozygous R952H variant in the SLC12A5 gene in 3 affected members of an Australian family with febrile seizures. Segregation of the variant in this kindred was difficult because of uncertain phenotyping, but there was some evidence of incomplete penetrance. In vitro functional expression studies showed markedly decreased surface expression of the mutant protein (61% of wildtype) as well as decreased chloride extrusion compared to wildtype. Thus, the mutant protein was associated with deficits in maintaining the chloride driving force required for hyperpolarizing GABA-mediated responses. Transfection of the variant into rats and into mouse cortical neurons showed that it compromised dendritic spine formation and maturation. Puskarjov et al. (2014) suggested that the decrease in SLC12A5-dependent hyperpolarizing inhibition would promote triggering of seizures, and that decreased dendritic spine formation could lead to desynchronization of overall excitability, which may also contribute to seizures.


REFERENCES

  1. Kahle, K. T., Merner, N. D., Friedel, P., Silayeva, L., Liang, B., Khanna, A., Shang, Y., Lachance-Touchette, P., Bourassa, C., Levert, A., Dion, P. A., Walcott, B., and 11 others. Genetically encoded impairment of neuronal KCC2 cotransporter function in human idiopathic generalized epilepsy. EMBO Rep. 15: 766-774, 2014. [PubMed: 24928908] [Full Text: https://doi.org/10.15252/embr.201438840]

  2. Puskarjov, M., Seja, P., Heron, S. E., Williams, T. C., Ahmad, F., Iona, X., Oliver, K. L., Grinton, B. E., Vutskits, L., Scheffer, I. E., Petrou, S., Blaesse, P., Dibbens, L. M., Berkovic, S. F., Kaila, K. A variant of KCC2 from patients with febrile seizures impairs neuronal Cl- extrusion and dendritic spine formation. EMBO Rep. 15: 723-729, 2014. [PubMed: 24668262] [Full Text: https://doi.org/10.1002/embr.201438749]


Creation Date:
Cassandra L. Kniffin : 12/8/2015

Edit History:
carol : 06/14/2016
carol : 12/22/2015
ckniffin : 12/21/2015